版本:
中国

BRIEF-ObsEva starts key study testing nolasiban in ART

March 7 ObsEva SA

* Obseva starts phase 3 clinical program for nolasiban in art

* Obseva sa -initiation of phase 3 clinical program evaluating efficacy,safety of nolasiban to improve pregnancy,live birth rates in women undergoing art Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐